0      0

2020 Annual Meeting


AM20-34 - AM20-34: New Therapeutic Options for Patients with Sickle Cell Disease & Their Effect on the Transfusion Service


Oct 5, 2020 10:00am ‐ Oct 5, 2020 11:00am


Credits: None available.

Standard: $25.00
Members: $20.00

Description

Sickle cell disease (SCD) is an inherited condition that affects about 100,000 individuals in the United States. This disorder is familiar to the transfusion medicine professionals (Physicians; Technologists) since it relies heavily on transfusion of blood products - either via simple transfusion or RBC exchange. In recent years (2017-2019), newer potentially disease-modifying options were identified and approved by the FDA for use including l-glutamin, anyipolomerization agents (voxelotor) and P-selectin inhibitors (crizanlizumab). Furthermore, gene therapy might be a real option for cure of the disease. This session will concentrate on the education of Transfusion Medicine professionals on these advances and their possible implications for clinical practice and subsequent potential effect on the transfusion service.

Learning Objectives:
  • Describe the recent advances in gene therapy as a potential cure for Sickle Cell Disease (SCD)
  • Summarize the newly approved drugs for SCD and their respective mechanism of action.
  • Recognize the advances in the practice of RBC exchange for SCD - indications as well as desired parameters ( Hematocrit ; FCR)

Speaker(s):

Credits Available


AM20-34: New Therapeutic Options for Patients with Sickle Cell Disease & Their Effect on the Transfusion Service Evaluation

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content